The purpose of this study is to explore the effects of Oropharyngeal administration of colostrum to very low birth weight infants on sIgA and lactoferrin, in order to explore the protect immune function of colostrum to very low birth weight infants, to improve the utilization of breast milk and reduce infection rates of very low birth weight infants.
The number of very low born weight infants increased every year.they are suffer from many questions.Recent studies have shown that Oropharyngeal administration of colostrum to very low birth weight infants can reduce the time reach full enteral nutrition .But there are no evidence support that it can promote infants' immune response. The hypothesis of the current study is that Oropharyngeal administration of colostrum to very low birth weight infants may increase the secretion of sIgA in urine and saliva. The current study adopts randomized, double blind, controlled intervention trial, gives Oropharyngeal administration of colostrums to very low birth weight infants in intervention group and Oropharyngeal administration of Normal saline to control group. All indicators in this study are discrete traits, for sIgA、Lactoferrin number in Saliva and urine, number of CRP,time Begin oral feeding,time up to full enteral feeding, Person's chi-square tests were used for comparisons. For Blood culture results,The number of necrotizing enterocolitis (NEC) occurred, the investigators use Chi-square tests for comparisons between two groups. The study expects that Oropharyngeal administration of colostrum to very low birth weight infants can increase the secretion of sIgA in urine and saliva.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
64
rubbing drops of colostrum inside a baby's cheeks using a sterile syringe
rubbing drops of Normal saline inside a baby's cheeks using a sterile syringe
Change from Baseline in sIgA at 7 days
in urine and saliva
Time frame: at baseline(first time baby in hospital) and at 7 days
Change from Baseline in lactoferrin at 7 days
in urine and saliva
Time frame: at baseline(first time baby in hospital) and at 7 days
Change from Baseline in sIgA at 21 days
in urine and saliva
Time frame: at baseline(first time baby in hospital) and at 21 days
Change from Baseline in lactoferrin at 21 days
in urine and saliva
Time frame: at baseline(first time baby in hospital) and at 21 days
The duration from admission to the start of oral feeding
when the first time participants start bottle feeding by mouth(\>5ml/once)
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 days
The duration from the start of enteric feeding to full enteric feeding
when the volume of milk participants take by mouth up to 140ml/kg/day
Time frame: participants will be followed for the duration of hospital stay, an expected average of 14 days
The number of participants with necrotizing enterocolitis (NEC)
Time frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.